| Syncom Formulations (India) Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524470 |
NSE Symbol : SYNCOMF |
P/E(TTM) : 22.42 |
|
ISIN Demat : INE312C01025 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.67 |
|
Book Value(₹) : 4.00 |
Market Cap(₹Cr) : 1,411.88 |
Face Value(₹) : 1.00 |
| Board Of Directors | |
|---|---|
| Chairman & Exec. Director |
Kedarmal Bankda
|
| Chairman / Executive Director / WTD |
ANKIT KEDARMAL BANKDA
|
| Company Sec. & Compli. Officer |
Vaishali Agrawal
|
| ED / MD / Promoter |
Vijay Bankda
|
| Independent Non Exe. Director |
Ruchi Jindal
Ritesh Kumar Lunkad
Ankit Jain
|